$26.68 1.2 4.6%
Last Trade - 05/03/21
| Market Cap | £5.35bn |
| Enterprise Value | £7.41bn |
| Revenue | £574.2m |
| Position in Universe | 1091st / 6651 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 0.000 | 746.1 | 778.3 | 815.9 | 893.2 | +4.3% | ||
| +4,032 | +81.4 | |||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Sotera Health Company., is a medical device company. The Company is a provider of sterilization and lab testing and advisory services to the medical device and pharmaceutical industries. The Company has three segments: Sterigenics, Nordion and Nelson Labs. It focuses on sterilization services and lab services. The Sterilization Services includes products, such as medical protective barriers, including personal protective equipment, procedure kits and trays, catheters, wound care products, laboratory products and pharmaceuticals. The lab services offer microbiology testing services, analytical chemistry lab testing and advisory services. Medical device lab testing services include microbiology, biocompatibility and toxicology assessments, sterility assurance, packaging validation and distribution simulation, and reprocessing validations. The pharmaceutical lab testing services include microbiology, biocompatibility and toxicology assessments, extractables and sterilization validation.
| Last Annual | December 31st, 2019 |
| Last Interim | September 30th, 2020 |
| No. of Shareholders: | n/a |
| No. of Employees: | 2,900 |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | Nasdaq Composite , |
| Exchange | NASDAQ Global Select Market |
| Shares in Issue | 277,431,755 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 9100 South Hills Blvd,Suite 300 Suite 300, BROADVIEW HEIGHTS, 44147, United States |
| Web | https://soterahealth.com/ |
| Phone | +1 440 2621410 |
| Contact | () |
| Auditors | Ernst & Young LLP |
As of 05/03/21, shares in Sotera Health Co are trading at $26.68, giving the company a market capitalisation of £5.35bn. This share price information is delayed by 15 minutes.
Shares in Sotera Health Co are currently trading at $26.68 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Sotera Health Co price has moved by % over the past year.
There are no analysts currently covering Sotera Health Co.
Sotera Health Co is scheduled to issue upcoming financial results on the following dates:
Sotera Health Co does not currently pay a dividend.
Sotera Health Co does not currently pay a dividend.
Sotera Health Co does not currently pay a dividend.
To buy shares in Sotera Health Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Sotera Health Co are currently trading at $26.68, giving the company a market capitalisation of £5.35bn.
Here are the trading details for Sotera Health Co:
Based on an overall assessment of its quality, value and momentum, Sotera Health Co is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Sotera Health Co are currently priced at $26.68. At that level they are trading at 21.1% discount to the analyst consensus target price of 0.00.
Analysts covering Sotera Health Co currently have a consensus Earnings Per Share (EPS) forecast of 0.376 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sotera Health Co. Over the past six months, the relative strength of its shares against the market has been %. At the current price of $26.68, shares in Sotera Health Co are trading at 0.03% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Sotera Health Co.
We were unable to find the directors for Sotera Health Co.
Here are the top five shareholders of Sotera Health Co based on the size of their shareholding:
